ABSTRACT
INTRODUCTION
Steroid control of tissue-specific gene expression depends on several distinct classes of transcription factors, each binding to specific DNA sequences located in cis to the gene. Of these factors, the steroid receptors mediate the hormone response. Binding of a receptor molecule to its ligand triggers the interaction with so-called hormone response DNA elements (HRE) and the subsequent activation of nearby genes (for a review see reference 1). The presence of a steroid receptor in a given tissue is not sufficient to acquire the activation of all genes that are potentially responsive to the hormone. This can be concluded from the fact that each cell type containing a specific receptor such as the glucocorticoid or the oestrogen receptor responds to the hormone by activating only a limited set of the potentially responsive genes. What then may be the molecular mechanism that is responsible for the tissue-specific expression of genes, that are dependent on the administration of steroid? It probably requires the interplay of the steroid receptors with tissue-specific transcription factors resulting in rra/u-activation of promoters and enhancers, or opening of the chromatin (1) (2) (3) (4) (5) .
HREs act as inducible enhancers by increasing the rate of transcription from promoters in a relative orientation-and position-independent manner. A single HRE placed next to the TATA box is sufficient to mediate transcriptional induction (6, 7) . Combinations of at least two HREs or HREs combined with recognition sites for ubiquitous or cell-type restricted transcription factors act synergistically, to mediate hormone-controlled transcriptional activation (7 -11) .
Transcription factors that are restricted to or enriched in liver have been identified by protein-DNA interactions and in vitro transcription systems (12) (13) (14) (15) (16) (17) . Recognition sites for tissuespecific factors can act alone with only a TATA box, or in conjunction with other DNA elements recognized by tissuespecific or ubiquitous factors, to induce tissue-specific expression from templates containing homologous or heterologous promoters (16) (17) (18) (19) .
The promoter of the apo Very Low Density Lipoprotein gene (apoVLDL II) (20, 21) was chosen as a model system for studying oestrogen-controlled liver-specific gene expression. Activation of the gene by oestrogen in liver is accompanied by changes in the chromatin conformation of the region just upstream of the transcription initiation site. This is inferred from the appearance of a set of DNasel-hypersensitive sites within the 300-bp 5'flanking region (22) and altered reactivity towards dimethylsulfate (DMS) of several guanosines within the first 230 bp (23) . Most of the protein-guanosine contacts mapped in vivo could be grouped into distinct clusters indicating the presence of multiple protein-binding sites. Some of these sites resemble established recognition sequences, notably a sequence around position -54 which is clearly homologous to the COUP-element present in the ovalbumin promoter (24) and palindromic sequences centered around positions -171 and -215 conforming to a full and half ERE, respectively (25) (26) (27) . By transient expression (28) it was established that the palindromic sequence at -171 functions as an independent ERE on the homologous apoVLDL II and the heterologous thymidine kinase promoter, and that the imperfect palindrome at -215 enhances the oestrogen response.
Ill the present paper, the interaction of transcription factors with DNA within the 30O-bp upstream region was analysed in further detail by genomic DNAase I footprinting, in vitro DNAase I footprinting, and recognition site competition assays. We find protein-DNA interactions at multiple sites, specifically the ERE, a COUP-element and sites resembling the recognition sequences of C/EBP (29) , DBP (30) and LF-A1 (17, 31) .
MATERIALS AND METHODS Animals and hormonal induction
Rhode Island Red roosters and immature hens were 6-10 weeks and laying hens 8 months old. Oestrogen stimulation of roosters was achieved by a s.c. injection of 50 mg per kg body weight of 17-/3-oestradiol 3 days prior to the isolation of nuclei.
Genomic DNAase I footprinting
Nuclei were prepared according to the procedure of Gorski et al. (32) . The livers were perfused with ice-cold phosphatebuffered saline (PBS; 8.1 mM Na^Pd, 1.5 mM KH 2 PO 4 , 140 mM NaCl, 2.5 mM KC1, pH 7.5). When livers from oestrogentreated roosters or laying hens were used, 5 jtM 17-/3-oestradiol was added to all solutions. Nuclei were resuspended (33) in buffer A (15 mM Tris-HCl, pH 7.4, 60 mM KC1, 15 mM NaCl, 1 mM phenyl methyl sulphonyl fluoride (PMSF), 0.2 mM EDTA, 0.2 mM EGTA, 0.15 mM spermine and 0.5 mM spermidine) to a concentration of 0.5 mg DNA/ml and treated with different amounts of DNasel (0-1000 U DNasel per mg DNA). Digestion was started by adding CaCl 2 and MgCl 2 to 1 mM and 10 mM final concentration, respectively, and was allowed to proceed for 5 min at 0°C. The reaction was stopped by the addition of EDTA to 150 mM and sodium dodecylsulphate to 0.5%. DNA was isolated as described (23) , cleaved with a restriction enzyme, extracted with one vol phenol:chloroform (1:1), extracted twice with chloroform, ethanol-precipitated and dissolved in formamide dye.
DNA cleavage, electrophoretic separation, electroblotting, radiolabelling of M13 probes, hybridization, and the preparation of DMS genomic sequence markers were performed as described (23, 34, 35) .
Nuclear extract preparation
Liver nuclear extracts from oestrogen-treated roosters were prepared as described by Lichtsteiner et al. (36) . Livers were perfused with ice-cold PBS to remove erythrocytes. The crude nuclear extracts were dialyzed twice for 2 hr at 4°C against buffer D (25 mM HEPES, pH 7.9, 40 mM KC1, 10% glycerol, 0.1 mM EDTA, 1 mM dithiothreitol), centrifuged for 5 min in an Eppendorf centrifuge to remove aggregated material, then frozen in small aliquots in liquid N 2 and stored at -80°C.
DNAase I footprinting in vitro
An apoVLDL II Bglll/BamHI fragment extending from base pair -553 to +34 was labelled at its BamHI site, either with T4-polynucleotide kinase and [-y- 32 P]ATP, or with Klenow enzyme and [a^PJdATP. After labelling, the DNA was cleaved with BgHI, the fragments separated on a 4% polyacrylamide (30:1) gel and the 600-bp fragment isolated by isotachophoresis (37) .
The binding reaction was in binding buffer (20mM HEPES, pH 7.9, 60 mM KC1, 0.06 mM EDTA, 0.6 mM DTT, 2 mM spermidine, 10% glycerol) supplemented with 2.5 ng poly(dldC), 100 nM 17-/3 oestradiol, and up to 5 /tl of nuclear extract (80 /ig) in a final volume of 50 /*1. After 10 min at 0°C, 3 to 5 ng of the end-labelled fragment were added and the mixture was incubated for 60 min at 0°C, followed by a 20-min incubation at 25°C. The mixture was then put on ice-water for 5 min; then 2.5 /il freshly diluted DNAase I (25-200 /ig/ml) in 10 mM HEPES [pH 7.9], 25 mM CaCl 2 , 117 mM MgCl 2 and 100 /xg/ml BSA were added, and digestion was allowed to proceed for 2 min at 0°C. Reactions were stopped by adding 200 /A of 20 mM Tris [pH7.5], 20 mM EDTA, 0.5% SDS. The DNA was extracted twice with phenol:chloroform (1:1 v/v), once with chloroform, ethanol-precipitated, dissolved in 80% formamide, 10 mM EDTA with tracking dyes, heated at 90°C for 3 min and loaded on 6% polyacrylamide (20:1) -7 M ureum gels. G > A sequence reactions on the appropriate end-labelled fragment were done as described (38) . In some experiments the nuclear extract was heated for 10 min at 70°C, cooled on ice, and centrifuged for 3 min prior to the binding reaction.
For competition footprint analysis, the binding mixture was pre-incubated with the appropriate amounts of double-stranded oligonucleotide before the labelled DNA-fragment was added.
Gel retardation assays and competition studies
The probes used in gel retardation assays were chemically synthesized oligonucleotides. Fifty nanograms of single-stranded oligonucleotide (gel-purified) were 32 P-Iabeled with T4-polynucleotide kinase. DNA was separated from nonincorporated radio-label by Sephadex G-50 gel chromatography, mixed with 2 ng of poly(dl-dC) carrier DNA, ethanolprecipitated, washed with 96% ethanol, dried under vacuum, and redissolved in 20 /xl of 10 mM Tris (pH 7.5), 50 mM NaCl, 10 mM MgCl 2 , 1 mM EDTA and 1 mM DTT, containing a fourfold excess of the opposite strand oligonucleotide, as described by Wall et al. (39) . The mixture was heated for 2 min at 90°C in a water bath, and annealing of the strands was allowed to occur by cooling slowly to room temperature. Unlabelled oligonucleotides were annealed similarly, except that carrier DNA was omitted and equal amounts of both strands (0.25 ng/fii) were used.
The standard gel retardation assay contained in a final volume of 15 id: binding buffer, supplemented with 2 /tg poly(dl-dC), 0.1 ng of labelled oligonucleotide and 0.4 ng of the unlabelled complementary oligonucleotide, 1 /tl nuclear extract (3 or 9 /ig//tl) in dialysis buffer. The extract was pre-incubated 10 min on icewater before adding the labelled double-stranded oligonucleotide and the mixture was incubated for 20 min at 25 °C. The samples were loaded on pre-runned (30 min 100 V) 4% (30:1) polyacrylamide gels and run for 1 h at 180 V in 0.5xTBE at room temperature. For competition experiments, the competitor oligonucleotide was included in the pre-incubation mixture. Fragment A', containing the COUP-sequence, was obtained by annealing oligonucleotides GATCCCTATGGTGTCAAAGGT-CAAAG and GATCCTTTGACCTTTGACACCATAGG. Fragment OCT, containing the octamer motif, was obtained by annealing oligonucleotides CTAGAAGAATTTGCATGC-AAAAGAGT and CTAGACTCTTTTGCATGCAAATTCTT.
Nucleotide sequences of the oligonucleotides

RESULTS
Genomic DNAase I analysis of the apoVLDL II promoter reveals that in the expressing liver, proteins bind to the ERE and several other sites Binding of proteins to DNA as it occurs in native chromatin was investigated by genomic DNasel footprinting (33, (40) (41) (42) . Nuclei from liver of the laying hen and oestrogen-treated cockerel expressing the apoVLDL II gene were compared to the following non-expressing tissues: liver from hormone-naive cockerel and immature hens, spleen and laying hen oviduct. The DNasel cleavage sites mapped from the PvuTI site at -300 directed downwstream and from the BstETI site at +103 directed upstream are shown in Figures 1 and 2 , respectively. In non-expressing tissue, regardless whether it concerns non-induced liver, oviduct or spleen, the larger part of the region investigated displays a more or less periodic DNasel cleavage pattern. This can for example be seen in the region downstream of position -100. In the hormone-stimulated livers, several regions appear protected when compared to the non-expressing tissues. Close to the gene, we find a large footprint extending to position -98. Contrary to the distal boundary which is rather sharp, the proximal boundary is less defined. Based on the location of a DNasel hypersensitive site in the genomic footprint of expressing liver, nt -40/-41 was taken as the proximal boundary. The footprint coincides with a cluster of protein-guanosine contacts in vivo (23) . The footprint extends over 5 helical turns and most probably involves binding of several proteins to the DNA. One of these proteins may be the ubiquitous COUP transcription factor, as is suggested by the similarity of its recognition sequence 5'-TG-ACCTTTGACAC-3' to the apoVLDL H sequence 5'-GGACC-TTTGACCC-3' between nucleotides -48 and -60. Anticipating the evidence from in vitro DNasel footprinting, this COUP-like element is found within a separate footprint A. The remainder of the footprint is indicated as site B, and could by itself accomodate more than one protein.
Proceeding into the upstream direction, we encounter a second region of protein-DNA interaction separated from the geneproximal footprint by a couple of hypersensitive sites and extending to base pair -186. Non-protected cleavage sites around position -142 divide the region into a downstream (3') moiety (designated C) which is protected relatively weakly and an upstream (5') moiety (D/Ej) which is protected more clearly. The latter region contains two established recognition sequences. Firstly, the sequence 5'-CCATTACCAAATC-3' from -162 to -150 is strikingly similar to the sequence 5'-CCATTACaAA-ATC-3' (mismatch in lower case) of the D-element of the mouse albumin promoter (36) . The albumin D element is the target site for two different, liver-enriched proteins, C/EBP (29, 43, 44) , and DBP (30) . Secondly, the sequence 5'-GGTCAGACTG-ACC-3' from -177 to -165 represents an ERE. Additional footprints can be noticed further upstream (Fig. 2) , one I approximately covering the imperfect ERE sequence centered around position -215 (site EJ and another from nt -234 to -283 (site F). These footprints were confirmed (data not shown) by probing the region between the Bgin site at -553 and the Hinfi site at -134 with the appropriate probes (23) . The in vivo footprinting data together with those from the in vitro footprinting discussed below, are summarized in Fig. 3 .
In summary, genomic DNAase I footprinting performed on isolated nuclei revealed protein-DNA interactions within the apoVLDL II 5' flanking region that are liver-specific and oestrogen-dependent. The footprints coincide with previously identified guanosine-protein contacts in vivo, and include a COUP-box, a putative C/EBP or DBP recognition sequence and an oestrogen response element.
Interaction of chicken liver nuclear proteins with the promoter region of the apoVLDL II gene
To further investigate the individual protein binding sites, we turned to in vitro DNasel footprinting. Proteins contained in the liver nuclear extract from oestrogen-stimulated cockerel protect several regions upstream of the cap site (Fig. 4) . One of the prominent footprints perfectly matches the proximal site A/B found in vivo (see lanes 12, Fig. 4 and lanes 16, Fig. 6 ). A second strong footprint covers site D, which forms part of the larger in vivo footprint C/D/E|, and a third one is centered around position -260 (Fig. 6 ) and corresponds to the distal DNasel footprint F found in vivo. Compared to site D, the adjacent ERE sequence exhibits only weak protection (Fig. 6 , compare lanes 1 and 3) which becomes more pronounced at higher concentration of nuclear extract (data not shown). Weak protection is also observed on the imperfect ERE around position -215. The latter sequence is bounded by a DNasel hypersensitive site at position -222/-220 suggesting that it is involved in protein-DNA interaction. In some experiments (not shown) a weak footprint was present on site C. A summary of the data is included in Fig. 3 .
In summary, the sites within the apoVLDL II5' flanking region protected in vitro against DNasel by liver nuclear proteins largely coincide with in vivo binding sites mapped by genomic footprinting.
A heat-stable factor binds at multiple sites upstream of the apo VLDL II gene ApoVLDL II site D is of particular interest because of its proximity to the ERE at -171. Because C/EBP which binds to the albumin element D is known to be heat-stable (43, 44), we examined the thermal stability of the binding activities present in liver nuclear extracts. Extracts treated for 10 min at 70°C retained the capacity to protect sites B and D (Fig. 4) .
Sites B and D are recognized by the same heat-stable nuclear proteins as can be concluded from competition DNasel footprinting (Fig. 4) . Oligonucleotide D not only competes the binding on its cognate site D, but on site B as well (Fig. 4, left  panel) . The same holds for the complementary experiment in which an oligonucleotide corresponding to the right moiety of site B (B], see Materials and Methods) is used as competitor (Fig. 4, right panel) . In view of its size, site B could possibly accommodate two proteins. Indeed, proteins binding to this site are not only competed by oligonucleotide B, but by oligonucleotide B2 corresponding to a non-overlapping moiety of site B, as well (data not shown). Competition band-shift experiments using native nuclear extract confirmed the overlapping binding specificities of sites B|, B2 and D. Binding of nuclear proteins to radiolabelled oligonucleotides representing these sites (Fig. 5, panels B, E and C) is inhibited by an excess of the corresponding or the two other unlabelled oligonucleotides. On the other hand, oligonucleotides A, C, E, and E2 do not compete for the proteins binding to sites Bi, B2 and D, demonstrating the specificity of the interaction. The binding is marked by the formation of two complexes with different mobilities. When the nuclear extract was treated at 70°C prior to interaction with the oligonucleotide, for example oligonucleotide D (Fig. 5, panel F) , only the complex with the higher mobility is maintained implying that it contains the heatstable factor.
In summary, elements B,, B2 and D of the apoVLDLH promoter region bind the same heat stable protein(s).
Nuclear proteins binding to element D and the adjacent ERE interfere
To investigate the possible interference between different DNAbinding proteins, we continued the in vitro DNAase I competition assays using the native nuclear extract and an extended set of competitor oligonucleotides (Fig. 6) . First, the experiments confirm that the larger footprint between nt -42 and -97 represents at least two different binding sites, site A and site B, which are competed by the corresponding oligonucleotides only (lanes 4, 5 and 11). Secondly, the experiments reveal interference between the proteins recognizing sites D and E. When site D is fully protected, only a faint footprint is visible on site E) (lane 3). However, when protein binding to site D is prevented by an excess of competitor oligonucleotide B,, B2 or D (lanes 5, 6, 7 and 11) the footprint on site E) becomes more pronounced. Under the conditions of the in vitro footprinting assay, occupation of site D might sterically hinder protein interaction with site E ( . Only when site D is cleared, site E\ becomes accessible to interact with a DNA-binding protein, which in turn can be dissociated by adding an excess of oligonucleotide E) (lane 8). However with site D fully protected, a weak footprint can still be formed on site E| which can be competed by an excess of oligonucleotide E, Qant 13). This simultaneous binding is in apparent contradiction to the observed interference. These observations may be explained by the presence of two different proteins recognizing site D, one excluding the protein binding to site E b and the other allowing the simultaneous occupation to occur. Actually, the occurrence of two different proteins recognizing site D has been suggested by the band-shift experiment (Fig. 5 F) , in which oligonucleotide D gave rise to two bands one of which is heat stable. This resembles the situation at the albumin D element which is recognized by C/EBP and DBP.
In summary, a protein recognizing element D interferes with the binding of a protein to the adjacent oestrogen response element.
The COUP elements of the chicken ovalbumin promoter and element A of the apoVLDL II promoter are recognized by the same transcription factor Competition DNasel footprinting established the boundaries of site A (Fig. 6, lanes 5, 6 and 11 ). Site A, binding a heat-labile protein (Fig. 4, lanes 11 and 14) , resembles the chicken ovalbumin upstream promoter element (COUP) and may bind the ubiquitous COUP transcription factor (24) . Indeed, the retarded complex (Fig. 5, panel A) formed between a radiolabelled double-stranded DNA fragment containing site A upon incubation with liver nuclear extract, is dissociated not only by an excess of unlabelled homologous competitor, but by the authentic COUP sequence as well. Similarly, protein binding to the labelled COUP sequence was competed by both competitors, COUP and A (data not shown). These experiments show that both apoVLDL II site A and the ovalbumin upstream promoter element COUP are recognized by the same nuclear factor, which is either the COUP factor or a factor with similar binding specificity.
Competition band-shift experiments revealed yet another factor. When protein interaction with oligonucleotide A was challenged with different competitor oligonucleotides no competition was found with sequences based on the other apoVLDL II elements including element C. On the other hand, the retarded complex formed with radiolabelled oligonucleotide C is competed not only by the homologous oligonucleotide, but also by oligonucleotide A and oligonucleotide COUP (Fig. 5, panel D) . This points to a second factor, different from the COUP transcription factor, binding both to site C and site A. This shared affinity probably reflects the sequence similarity of site A, GGACCTTTGACC, to site C, GGACTCTGGACC, which amounts 10 out of 13 nucleotides. These sequences are reminiscent of the regulatory sequences GAACCCTTGACC in the human apo-A| gene which is the target site of the liver-enriched transcription factor LF-A1 (17, 31) .
In summary, site A is recognized by two proteins, one being the ubiquitous COUP-transcription factor. The other protein also binds to site C and may be the liver enriched LF-A1 as is suggested by the similarity of binding sequences.
DISCUSSION
We have applied genomic DMS (23) and DNasel footprinting, as well as in vitro DNasel footprinting and band-shift analysis to investigate protein-DNA interactions in the apoVLDL II promoter region. These studies have revealed multiple binding sites for distinct proteins within the 300-bp sequence 5' flanking the gene. The sites found in native chromatin of the liver, are essentially reproduced by the binding in vitro of liver nuclear proteins from oestrogen-stimulated birds to cloned DNA. In vivo, binding of proteins is effectuated only after the animal is stimulated by oestrogen and, importantly, appears to occur on all the different sites. Liver nuclear extracts from oestrogen stimulated rooster and laying hen gave protections similar to those of control rooster, and the addition of oestrogen to the binding assay was without effect (data not shown). This implies that all proteins are present irrespective of the hormonal status of the liver. In vivo, the actual binding of the receptor to its target site is thought to require its activation by the ligand, resulting in the recruitment of other factors onto the DNA. Under the in vitro conditions, oestrogen dependency of binding appears to be relaxed and the different proteins can bind independently.
In a region extending from nt -40 to -280 relative to the cap site, eight distinct regions of protein-DNA interaction are found (Fig. 7) . Site E, located between positions -177 and -165, containing the sequence GGTCAGACTGACC and functioning as an oestrogen response element (28) , is the recognition sequence of the oestrogen receptor (25) (26) (27) .
The most likely protein binding to site A is the COUPtranscription factor as was initially inferred from similarity of recognition sequences and further substantiated by competition DNasel footprint and band-shift analysis. The COUPtranscription factor is present in a number of different tissues and is a member of the steroid receptor superfamily of gene regulators. Another protein present in liver nuclear extracts has affinity for sites A and C. As argued above, LF-A1 is a likely candidate. Since both COUP-TF and LF-A1 act as 'bona fide' transcription factors in vitro (17, 24, 31, 45) , their binding to the same site or overlapping sites may reflect a redundancy of transcription factors each of which can help in the stimulation of transcription and/or in stabilization of a transcription complex. Preliminary experiments using LF-A1, purified from calf liver by site-specific DNA affinity chromatography (31) , and antiserum against COUP-TF (39) showed that both sites A and C are recognition sites for LF-A1 and that site A is recognized by COUP-TF (J. Wijnholds and G. AB, in preparation).
Although sites Bj, B2 and D show little sequence similarity, our experiments demonstrate that they bind a common heat-stable protein. When the individual sites were compared to recognition sequences of known transcription factors, we noticed the following similarities. The sequence ATTTGCTTGCAAAA of site B2 shows some similarity with the recognition site, ATGC-AAAT, for octamer transcription factors, OTFs (46) . However, a variant B 2 oligonucleotide bearing the sequence ATTTGCATGCAAAA with the authentic octamer motif in the lower strand, did not challenge the protein binding to site B2, nor to sites I*! and D (Fig. 5, panel E) . Therefore, these sites are not recognition sequences for OTFs. Similarly, no crosscompetition (data not shown) was observed with oligonucleotides based on the adeno virus NF-1 recognition sequence (47, 48) and the recognition site for a NF-1 like activity in liver nuclear extracts (49) . Having excluded the OTF and NF-1 classes of proteins as the binding activity for site Bi, B2 and D, the chicken analogues of C/EBP and DBP remain as the most likely candidates. C/EBP and DBP are suggested because of the similarity (12 out of 13 nucleotides) of apoVLDL II site D to their binding sequence (site D) in the albumin promoter. Moreover, at least some of the proteins binding to sites B,, B2 and D are heat stable as is C/EBP. In addition, site B[ has been shown to direct /ra/u-activation of the apoVLDL II promoter by C/EBP from a C/EBP expression vector in gene transfer experiments (28) . Binding of chicken DBP to element D was recently established by cloning a DNA binding protein from a chicken liver lambda gtl 1 library using a recognition site DNA probe corresponding to element D (Wijnholds et ai, in preparation). Our chicken clone shows high similarity with the rat DBP sequence (30) .
The configuration of binding sites D and E, which are adjacent to each other or may even overlap partially is interesting. In the expressing liver both sites are occupied simultaneously, whereas the in vitro competition DNasel footprinting reveals that the proteins binding to both sites interfere. The proximity of the ERE and site D is reminiscent of the situation in the glucocorticoid regulated tyrosine amine transferase (TAT) gene, where a GRE at -2.5 kb in front of the gene is flanked by a CCAAT element (7) . Whereas a single GRE placed at a large distance can not confer glucocorticoid inducibUity to a promoter, the combination of CCAAT element and GRE can and is called a glucocorticoid responsive unit (GRU). The simultaneous occupation in vivo of sites E] and D suggests that the factor binding to site D may interact with the oestrogen receptor and stabilize its binding to site E|. Whether the combination of elements D and E[ forms an oestrogen response unit is under investigation. Under in vitro binding conditions, the dual occupation of sites D and Ej is not the dominant state but rather the single interaction of a protein with site D excluding binding to site E^ A possible explanation is that one of the factors binding to site D excludes occupation of site E, whereas the other D-binding protein allows simultaneous occupation. Another possibility might be that binding of the oestrogen receptor must precede binding of C/EBP and DBP to their respective sites.
Whatever the specific role of the different proteins in apoVLDL II transcription regulation is, they should not only provide an explanation for the mechanism of transcription activation but also for the complete suppression of transcription in liver in the absence of oestrogen and in oviduct. In hormone-naive liver the available COUP-, and liver-enriched transcription factors are unable to form a stable transcription complex in the absence of activated oestrogen receptor. In oviduct, where activated oestrogen receptor, as well as COUP-TF, is available, the formation of an active transcription complex might be prohibited by the absence of liver-specific transcription factors. In both cases, the apoVLDL II promoter might be maintained in the silent state by interaction with nucleosomes. The activated receptor, assisted by liver-specific transcription factors, would then primarily act to make the promoter region accessible for the RNA polymerase complex (50, 51) .
